Results

Total Results: 158 records

Showing results for "stimulants".

1. ADHD, (Last ADHD visit >6 months), Overdue for follow-up | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
   digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/adhd-last-adhd-visit-6-months-overdue-follow
   January 01, 2001 - These visits also allow assessment of potential side effects of stimulants, such as decreased appetite

2. Pediatric Rules and Reminders - ADHD, (Last ADHD visit >6 months), Overdue for follow-up (pdf file)
   digital.ahrq.gov/sites/default/files/docs/page/adhd-overdue.pdf
   January 01, 2001 - These visits also allow assessment of potential side effects of stimulants, such as decreased appetite

3. Dataform 1 (pdf file)
   digital.ahrq.gov/sites/default/files/docs/resource/Dataform_1_Prescription_Screening_Form.pdf
   September 30, 2009 - Stimulants 35. Thyroid agents 36. Vaccines 37. Vitamins 38. Other 39.

4. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications - 2011 | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medications/annual-summary/2011
   January 01, 2011 - of electronic prescribing (e-prescribing) to cover federally-controlled substances (e.g., narcotics, stimulants

5. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications - 2012 | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medications/annual-summary/2012
   January 01, 2012 - of electronic prescribing (e-prescribing) to cover federally controlled substances (e.g., narcotics, stimulants

6. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medications
   January 01, 2022 - standards for the electronic prescribing of federally controlled substances (EPCS) (e.g., narcotics, stimulants

7. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications (pdf file)
   digital.ahrq.gov/sites/default/files/docs/activity/2011_017157_carrow_pdf_3.pdf
   January 01, 2011 - electronic prescribing (e-prescribing) to cover federally-controlled substances (e.g., narcotics, stimulants

8. The impact of stimulant medications on blood pressure and body mass index in children with ADHD. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/improving-recognition-and-management-hypertension-youth-comparing-approaches/citation/impact
   January 01, 2023 - The impact of stimulant medications on blood pressure and body mass index in children with ADHD. Citation Suess M, Chrenka EA, Kharbanda EO, Asche S, O'Connor PJ, Ekstrom H, Benziger CP. The impact of stimulant medications on blood pressure and body mass index in children…

9. Informing the design of a new pragmatic registry to stimulate near miss reporting in ambulatory care. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/decision-making-and-clinical-work-test-result-followup-health-information/citation/informing
   January 01, 2022 - Informing the design of a new pragmatic registry to stimulate near miss reporting in ambulatory care. Citation Pfoh ER, Engineer L, Singh H, et al. Informing the design of a new pragmatic registry to stimulate near miss reporting in ambulatory care. J Patient Saf 2017 Fe…

10. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/identifying-adverse-drug-events
    September 13, 2021 - Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report Authors:  Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, Burdick E, Seger DL, Vander Vliet M, Bates DW Journal:  J Am Med Inform Assoc Publication Date:  199…

11. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications (pdf file)
    digital.ahrq.gov/sites/default/files/docs/activity/r18hs017157-carrow-annual-summary-2012.pdf
    January 01, 2012 - electronic prescribing (e-prescribing) to cover federally controlled substances (e.g., narcotics, stimulants

12. Dataform 4: Chart Review form (pdf file)
    digital.ahrq.gov/sites/default/files/docs/resource/Dataform_2_Chart_Review.pdf
    September 30, 2009 - Stimulants 64. Thyroid agents 65. Topical anesthetic 66. Vaccines 67.

13. Forging a Pathway for Electronic Prescribing of Controlled Substances (pdf file)
    digital.ahrq.gov/sites/default/files/docs/page/forging-pathway-for-electronic-prescribing-of-controlled-substances.pdf
    March 01, 2014 - standards to prevent and detect the diversion of federally controlled substances, such as narcotics, stimulants

14. Benziger, Catherine | Digital Healthcare Research
    digital.ahrq.gov/principal-investigator/benziger-catherine
    January 01, 2023 - Benziger, Catherine Improving Recognition and Management of Hypertension in Youth: Comparing Approaches for Extending Effective CDS for use in a Large Rural Health System Description The aim of this research is to implemen…

15. Kharbanda, Elyse | Digital Healthcare Research
    digital.ahrq.gov/principal-investigator/kharbanda-elyse
    January 01, 2023 - Kharbanda, Elyse Improving Recognition and Management of Hypertension in Youth: Comparing Approaches for Extending Effective CDS for use in a Large Rural Health System Description The aim of this research is to implement a…

16. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications - 2010 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medication/annual-summary/2010
    January 01, 2010 - of electronic prescribing (e-prescribing) to cover federally-controlled substances (e.g., narcotics, stimulants

17. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications (pdf file)
    digital.ahrq.gov/sites/default/files/docs/activity/enabling_electronic_prescribing_and_enhanced_management_of_controlled_medications_2010pdf_2.pdf
    September 29, 2011 - electronic prescribing (e-prescribing) to cover federally-controlled substances (e.g., narcotics, stimulants

18. Physician response to computer reminders | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/physician-response-computer
    October 03, 1980 - Physician response to computer reminders Authors:  McDonald CJ, Wilson GA, McCabe GP= Jr Journal:  JAMA Publication Date:  1980 Oct 3 Volume:  244 Issue:  14 Pages:  1579-81 HIT Description:  Electronic health record and computerized decision support with reminders.  More info... Purpose of Study:  Evaluat…

19. Improving Diagnosis of Hypertension in Children - Final Report (pdf file)
    digital.ahrq.gov/sites/default/files/docs/citation/r21hs024100-rao-final-report-2018.pdf
    January 01, 2018 - Oral or Inhaled Steroids Yes No 38 (2.2%) 1687 (97.8%) 49 (2.9%) 1672 (92.1%) 0.2280 Stimulants … Oral or Inhaled Steroids Yes No 37 (2.1%) 1757 (97.9%) 49 (3.5%) 1353 (96.5%) 0.0130 Stimulants

20. Practical Solutions for Engaging Consumers in the Design and Use of PHRs: Beyond User Centered Design | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/events/practical-solutions-engaging-consumers-design-and-use-phrs-beyond-user-centered-design
    May 08, 2008 - Practical Solutions for Engaging Consumers in the Design and Use of PHRs: Beyond User Centered Design Event Details Date: May 8, 2008 Time: 1:30pm to 3:00pm Presenters: Patricia Brennan, University of Wisconsin-Madison; Kathy Hajopoulos, UCSF Medical Center; Teresa Zayas-Caban, Agency for Healthcare R…